Idacio 40 MG in 0.8 ML Injection
- RxCUI
- 2699319
- RxNorm name
- Idacio 40 MG in 0.8 ML Injection
- Display name
- Idacio 40 MG in 0.8 ML Injection
- Full name
- Idacio 40 MG in 0.8 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761255 | Idacio | adalimumab-aacf | 351(k) Biosimilar | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IDACIO | ADALIMUMAB-AACF | Fresenius Kabi USA, LLC | 08dbaffe-9d05-43cf-b24b-b44ade8685fc | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | 2699319 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 08dbaffe-9d05-43cf-b24b-b44ade8685fc | Idacio 40 MG in 0.8 ML Injection [PSN] · 0.8 ML adalimumab-aacf 50 MG/ML Injection [Idacio] [SBD] · Idacio 40 MG per 0.8 ML Injection [SY] | 3 | 1 | These highlights do not include all the information needed to use IDACIO safely and effectively. See full prescribing information for IDACIO . IDACIO® (adalimumab-aacf) injection, for subcutaneous use Initial U.S Initial U.S. Approval: 2022 IDACIO® (adalimumab-aacf) is biosimilar Guide: Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful | 20241015 |